Sponsored by

Chimerix

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 801 to 825 of about 5928

Previous 25

Website Changes

01/08/2021

Chimerix places its bets on Oncoceutics` dopamine antagonist for rare brain cancer in quest to salvage its image

01/08/2021

Kintara Therapeutics and Kazia Therapeutics drugs to enter glioblastoma trial

01/06/2021

Daiichi Sankyo Submits Application for Oncolytic Virus Teserpaturev (G47?) for Treatment of Patients with Malignant Glioma in Japan

01/05/2021

Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges

01/05/2021

Ovarian tissue cryopreservation and transplantation in patients with central nervous system tumours

01/01/2021

Musella Foundation awards three brain tumor research grants and reopens the brain tumor treatments copayment assistance program!

12/31/2020

Musella Foundation Copay Assistance Program is now open!

12/23/2020

Game changing brain surgery treatment gets Health Canada approval

12/23/2020

Bristol-Myers says Opdivo brain cancer study unlikely to meet overall survival endpoint

12/22/2020

After a 16 Year Battle with a Recurrent Glioma, Shannan Finds New Hope in GammaTile Therapy

12/21/2020

Mustang Bio and City of Hope Announce Initiation of Phase 1 Clinical Trial of MB-101 (IL13Ra2-specific CAR T cells) to Treat Leptomeningeal Brain Tumors

12/21/2020

Oncolytic Adenovirus in Combination With Pembrolizumab for Recurrent Glioblastoma

12/17/2020

Study Shows Typical Cancer-Free Survival Doubled for Recurrent Brain Cancer Patients when KIYATEC’s Test Informed Therapy Selection

12/16/2020

What Is a Cancer Commons Options Report?

12/15/2020

Novocure Announces National Reimbursement in Switzerland for Optune® in Combination With Temozolomide for the Treatment of Newly Diagnosed Glioblastoma

12/14/2020

Musella Foundation awards another brain tumor research grant!

12/10/2020

Oblato Announces Discussion Outcome with FDA for Development of OKN-007 for Diffuse Intrinsic Pontine Glioma

12/10/2020

`The Surgeon`s Cut` Review: Netflix docuseries is a moving look at pioneering doctors who overcame obstacles

12/10/2020

Kazia Therapeutics’ (ASX:KZA) brain cancer drug selected for international study

12/10/2020

PLUS THERAPEUTICS EXPANDS RESPECT™ CLINICAL TRIAL TO MD ANDERSON CANCER CENTER

12/10/2020

TVAX Biomedical announces major advancements in potential Glioblastoma cure

12/06/2020

Why Study Sexual Health in Patients With Lung Cancer?

12/06/2020

New Expanded Access Program for MAPK-Pathway Altered Cancers

12/01/2020

Concurrent Dexamethasone Limits the Clinical Benefit of Immune Checkpoint Blockade in Glioblastoma

11/30/2020

OncoSynergy Opens Enrollment for Clinical Trial of New Cancer Antibody Therapy, OS2966, in Patients with Recurrent Glioblastoma

Our privacy / cookie policy has changed.
Click HERE to read it!